Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc shares valued at $340,710 were sold by Mercier Johanna on Sep 15 ’25. At $113.57 per share, Mercier Johanna sold 3,000 shares. The insider’s holdings dropped to 113,193 shares worth approximately $12.87 million following the completion of this transaction.
Also, Dickinson Andrew D sold 2,500 shares, netting a total of over 283,925 in proceeds. Following the sale of shares at $113.57 each, the insider now holds 159,555 shares.
Before that, ANDREW DICKINSON had added 2,500 shares to its account. In a trade valued at $283,925, the Officer bought Gilead Sciences, Inc shares for $113.57 each.
As published in a research note from Daiwa Securities on August 19, 2025, Gilead Sciences, Inc [GILD] has been rated up from a Neutral to an Outperform and the price target has been revised to $128. Analysts at Truist upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early August. As of July 25, 2025, Needham has increased its “Hold” rating to a “Buy” for GILD.
Analyzing GILD Stock Performance
On last trading session, Gilead Sciences, Inc [NASDAQ: GILD] plunged -0.64% to $113.67. The stock’s lowest price that day was $111.98, but it reached a high of $114.57 in the same session. During the last five days, there has been a surge of approximately 1.26%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 35.42%. Shares of the company reached a 52-week high of $121.83 on 08/12/25 and a 52-week low of $88.57 on 01/10/25.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 112.23, which, if violated, would cause prices to drop to 110.79. In the upper region, resistance lies at 114.84. The next price resistance is at 116.01. RSI (Relative Strength Index) is 48.83 on the 14-day chart, showing neutral technical sentiment.
Is Gilead Sciences, Inc subject to short interest?
Stocks of Gilead Sciences, Inc saw a sharp steep in short interest on 2025-08-29 dropping by -2.43 million shares to 17.56 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 19.99 million shares. A decline of -13.83% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.79 of the overall float, the days-to-cover ratio (short ratio) decline to 2.79.
Which companies own the most shares of Gilead Sciences, Inc (GILD)?
In terms of Gilead Sciences, Inc share price expectations, FactSet research, analysts set an average price target of 125 in the next 12 months, up nearly 9.27% from the previous closing price of $114.4. Analysts anticipate Gilead Sciences, Inc stock to reach 143 by 2025, with the lowest price target being 108. In spite of this, 17 analysts ranked Gilead Sciences, Inc stock as Buy at the end of 2025. On March 04, 2025, Oppenheimer assigned a price target of “an Outperform” to the stock and reiterated coverage with a $132.
